Home » Newsletters » BioWorld Science

BioWorld Science

July 31, 2018

View Archived Issues

Sleep is depression's opposite

Novel CRISPR/Cas-mediated rat model of idiosyncratic drug-induced liver injury

First-in-human data presented for AB-023

Aspirin increases lysosomal biogenesis via PPARalpha and decreases amyloid plaque pathology in mice

Motile sperm domain-containing protein 2 promotes breast cancer cell migration and metastasis

Estrogen receptor alpha activation depends on fibronectin-beta1-integrin pathway in breast cancer

Bench and bedside: Phosphatase inhibition sheds ugly duckling status with new platform technology

Beta Cat studies BC-2059 for unresectable desmoid tumors in phase I

Primary endpoints met in phase IIb study of PRX for presbyopia

Phase III study of RHB-104 in Crohn's disease meets primary endpoint

Regenera initiates phase II study of RPh-201 in NAION

Dong-A conducts phase II study with DA-8010 in overactive bladder

First-in-human study investigates CALR exon 9 mutant peptide vaccine in CALR-mutant MPNs

Janssen studies PRMT5 inhibitor JNJ-64619178 in advanced cancers

FDA approves Azedra for pheochromocytoma or paraganglioma

Arcus cleared to begin phase I trial of anti-TIGIT antibody AB-154

Stop-gain variant in GMIP gene tied to Alzheimer's disease pathogenesis

Contactin-2 levels are altered in mild cognitive impairment

ASTRAL-1 study of guadecitabine in AML does not meet coprimary endpoints

Immutep to begin phase II study of eftilagimod alfa with pembrolizumab

Regeneus reports promising first-in-human data for autologous tumor vaccine RGSH-4-K

Phase II study of laquinimod in Huntington's disease does not meet primary endpoint

European Commission approves Aimovig to prevent migraines

HSP27 found as a potential therapeutic target for treating VCID

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...